Supplemental material for JAAD publication titled: Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate to severe plaque psoriasis: 24 Week results from a Phase III open-label, randomized, multicenter study

Name: Supplemental material for JAAD publication titled: Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate to severe plaque psoriasis: 24 Week results from a Phase III open-label, randomized, multicenter study
Creator: Bitumani Borah
License: 暂无描述

Mendeley Data2026-04-09 收录

下载链接：

https://data.mendeley.com/datasets/vn3spwfg52/4

下载链接

链接失效反馈

官方服务：

资源简介：

Supplemental material for JAAD publication titled: "A phase III open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results" to be published in Journal of the American Academy of Dermatology

提供机构：

Bitumani Borah